Etibo 250 mg

Name: Etibo 250 mg
Brand: Maheshwari Medical Agency
Price: 2400 INR
Availability: InStock

Price 2400 INR/ Bottle

Get a Price/Quote

MOQ : 2 Bottles

Etibo 250 mg Specification

Origin
India

Salt Composition
Erlotinib Hydrochloride 250 mg

Indication
Non-small cell lung cancer, pancreatic cancer

Dosage Form
Tablets

Feature
Prescription only, targeted therapy

Ingredients
Other

Application
Oral anticancer therapy

Physical Color/Texture
Light yellow, film coated tablet

Fermentation Smell
Odorless

Storage Instructions
Keep dry & cool place

Shelf Life
24 months

ATC Code
L01EB02

Warning
To be sold by retail on the prescription of an Oncologist only

Strength
250 mg per tablet

Manufacturer/Brand
Cipla

Generic Name
Erlotinib

Product Registration Number
As per local regulatory certifications

Administration Route
Oral

Packaging Type
Blister strip

Prescription Category
Rx Only

Batch Number Information
On outer pack

Etibo 250 mg Trade Information

Minimum Order Quantity
2 Bottles

Supply Ability
1000 Bottles Per Month

Delivery Time
7 Days

About Etibo 250 mg

Etibo 250 mg by Cipla is a hot-selling, exclusive oncology solution formulated with radiant expertise. Each light yellow, film coated, odorless tablet contains 250 mg of top-notch Erlotinib Hydrochloride, designed for oral administration. This inestimable prescription medicine, under ATC Code L01EB02, targets non-small cell lung cancer and pancreatic cancer with proven efficacy. Packaged in a convenient blister strip and registered as per local certifications, Etibo 250 mg offers limited time access for authorized healthcare providers. For safety, it requires an oncologist's prescription and must be stored in a cool, dry place. Proudly originating from India, Etibo 250 mg represents unparalleled quality from a trusted distributor, supplier, and trader.

Etibo 250 mg: Targeted Therapy Excellence

Etibo 250 mg is optimally used for oral anticancer therapy, primarily treating non-small cell lung cancer and pancreatic cancer. Its targeted mechanism offers a radiant, precise approach, maximizing treatment efficacy while limiting unnecessary side effects. As a top-notch prescription solution from Cipla, Etibo 250 mg meets stringent global regulatory standards, ensuring plant-origin performance and competitive advantages in potency and reliability. Its versatile application aligns with inestimable clinical needs across oncology practices.

Etibo 250 mg: Payment, Export Markets, and Swift Delivery

With stock ready for immediate shipment, Etibo 250 mg is available at a competitive sale price that reflects its superior value. Proposal amounts are tailored based on volume and destination market requirements. Our main export markets include Asia, Africa, Latin America, and the Middle East. Delivery time is swift and efficient, supporting urgent procurement needs for authorized medical distributors, suppliers, and traders globally.

FAQ's of Etibo 250 mg:

Q: How should Etibo 250 mg be administered for optimal results?

A: Etibo 250 mg should be administered orally, strictly following the oncologist's prescription and dosage guidelines. Ensure the tablet is swallowed whole with water and not crushed or chewed.

Q: What are the primary indications for prescribing Etibo 250 mg?

A: Etibo 250 mg is primarily indicated for the treatment of non-small cell lung cancer and pancreatic cancer as part of targeted anticancer therapy.

Q: When is Etibo 250 mg typically recommended by healthcare professionals?

A: Oncologists recommend Etibo 250 mg when targeted therapy with Erlotinib is deemed appropriate based on the cancer type and patient's medical profile. It is prescribed only after thorough clinical assessment.

Q: Where can Etibo 250 mg be legally purchased or sourced?

A: Etibo 250 mg is available only through registered pharmacies and authorized oncology distributors or traders. It can be sold by retail strictly on the prescription of a qualified oncologist.

Q: What benefits does Etibo 250 mg offer over traditional chemotherapy options?

A: Etibo 250 mg provides a targeted approach, minimizing the impact on healthy cells and potentially reducing the severity of side effects compared to traditional chemotherapy regimens, while delivering inestimable efficacy in specific cancer types.

Q: What storage conditions are required for maintaining Etibo 250 mg's quality?

A: Etibo 250 mg must be kept in a cool, dry place, away from moisture and direct sunlight, to preserve its effectiveness throughout its 24-month shelf life.

Tell us about your requirement